Related to Illumina Shuns Roche’s $5.7 Bid, While Roche Prepares for the Long Haul

• Tutorials: Assay: High-Throughput DNA Methylation
  
• Feature Articles: Next-Generation Sequencing Picks Up Pace
  
• Feature Articles: Managing Data from Next-Gen Sequencing
  
• Feature Articles: Next-Generation Sequencing Update
  
• Feature Articles: Honing In on Targeted Resequencing
  
• Feature Articles: Digital Gene-Expression Profiling
  
• Feature Articles: Novel Systems Zero In on the $100 Genome
  
• Assay Tutorials: Solutions for DNA Copy-Number Analysis
  
• Feature Articles: Next-Gen Sequencing Becoming Ubiquitous
  
• Feature Articles: Next-Gen Presents Array of Opportunities
  
• Feature Articles: Exploiting Multi-Methodological Synergies
  
• BioMarket Trends: NGS Market Remains on Upward Trajectory